INFO
Dies sind die Basisdaten für das ausgewählte Unternehmen. Diese Firma stellt weitere Informationen wie z.B. Webseite, Telefon- und Fax-Nummern, Ansprechpartner, Firmengeschichte, Details bereit.
Um diese Informationen einzusehen benötigen Sie einen gültigen "Profile Access" für glassglobal.com. Die Konditionen können Sie über folgenden Link: Preis Info einsehen
Kontakt Info
| Anschrift | SCHOTT Xinkang Pharmaceutical Packaging Co., Ltd No.8 Zuoku Industrial Zone, Huzhen Town, Jinyun County 321404 Zhejiang Province |
| Land | China |
| Ihre Nachricht an SCHOTT Xinkang Pharmaceutical Packaging Co., Ltd |
Produkte oder Maschinen
Marketed under the brand name FIOLAX®, SCHOTT borosilicate glass has been the gold standard for pharmaceutical packaging since it was first developed by the company’s founder Otto Schott in 1883. The material is highly inert and protects against any drug-container interaction, making it ideal for COVID-19 vaccines and other life-saving drugs.
SCHOTT sells the glass to third-party packaging manufacturers, but also converts the tubes to vials and other pharmaceutical containers in-house. Pharmaceutical vials made by SCHOTT are used in 75% of COVID-19 vaccine projects around the world.
Borosilicate glass, known under the SCHOTT brand name FIOLAX®, has been the preferred choice of material for pharmaceutical packaging since the company’s founder Otto Schott first developed it around 1890. The highly inert glass protects drugs from unwanted drug-container interactions, making it an ideal packaging material for life-saving drugs. More than 90% of all approved COVID-19 vaccines rely on SCHOTT’s glass tubing.
The manufacturing site will support the move away from the low borosilicate glass (so called 7.0 glass type) to the higher quality middle borosilicate glass (so called 5.0 glass type), which is already well established globally.
